Lipid droplets in Zika neuroinfection: Potential targets for intervention?


Journal

Memorias do Instituto Oswaldo Cruz
ISSN: 1678-8060
Titre abrégé: Mem Inst Oswaldo Cruz
Pays: Brazil
ID NLM: 7502619

Informations de publication

Date de publication:
2023
Historique:
received: 28 02 2023
accepted: 18 08 2023
medline: 13 10 2023
pubmed: 11 10 2023
entrez: 11 10 2023
Statut: epublish

Résumé

Lipid droplets (LD) are evolutionarily conserved lipid-enriched organelles with a diverse array of cell- and stimulus-regulated proteins. Accumulating evidence demonstrates that intracellular pathogens exploit LD as energy sources, replication sites, and part of the mechanisms of immune evasion. Nevertheless, LD can also favor the host as part of the immune and inflammatory response to pathogens. The functions of LD in the central nervous system have gained great interest due to their presence in various cell types in the brain and for their suggested involvement in neurodevelopment and neurodegenerative diseases. Only recently have the roles of LD in neuroinfections begun to be explored. Recent findings reveal that lipid remodelling and increased LD biogenesis play important roles for Zika virus (ZIKV) replication and pathogenesis in neural cells. Moreover, blocking LD formation by targeting DGAT-1 in vivo inhibited virus replication and inflammation in the brain. Therefore, targeting lipid metabolism and LD biogenesis may represent potential strategies for anti-ZIKV treatment development. Here, we review the progress in understanding LD functions in the central nervous system in the context of the host response to Zika infection.

Identifiants

pubmed: 37820117
pii: S0074-02762023000100855
doi: 10.1590/0074-02760230044
pmc: PMC10566564
pii:
doi:

Substances chimiques

Lipids 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e230044

Références

Pharmaceuticals (Basel). 2019 Jun 21;12(2):
pubmed: 31234348
N Engl J Med. 2009 Jun 11;360(24):2536-43
pubmed: 19516034
Gastroenterology. 2019 Aug;157(2):537-551.e9
pubmed: 30978357
Curr Opin Cell Biol. 2015 Apr;33:119-24
pubmed: 25703629
Annu Rev Microbiol. 1990;44:649-88
pubmed: 2174669
J Neuroinflammation. 2023 Mar 8;20(1):61
pubmed: 36882750
Sci Rep. 2017 Nov 1;7(1):14883
pubmed: 29093521
PLoS Pathog. 2009 Oct;5(10):e1000632
pubmed: 19851456
J Leukoc Biol. 2019 Sep;106(3):563-580
pubmed: 31121077
Curr Neurol Neurosci Rep. 2020 Sep 3;20(11):49
pubmed: 32880775
Neuroendocrinology. 2021;111(3):263-272
pubmed: 32422642
Sci Rep. 2019 Dec 30;9(1):20304
pubmed: 31889120
J Mol Biol. 2018 Mar 30;430(7):948-962
pubmed: 29454707
Mem Inst Oswaldo Cruz. 2012 Dec;107 Suppl 1:156-66
pubmed: 23283467
PLoS One. 2018 Oct 25;13(10):e0206093
pubmed: 30359409
J Cell Biol. 2021 Jul 5;220(7):
pubmed: 34152362
Prog Lipid Res. 2016 Oct;64:123-137
pubmed: 27702593
J Virol. 2020 Oct 27;94(22):
pubmed: 32878890
NPJ Parkinsons Dis. 2020 Jan 3;6:3
pubmed: 31909184
Cell Death Differ. 2001 Feb;8(2):113-26
pubmed: 11313713
Front Neurosci. 2020 Jul 29;14:742
pubmed: 32848541
Nat Neurosci. 2020 Feb;23(2):194-208
pubmed: 31959936
PLoS One. 2020 Dec 15;15(12):e0242367
pubmed: 33320867
Mol Cell Proteomics. 2018 Nov;17(11):2242-2255
pubmed: 30037810
Cell. 1997 May 2;89(3):331-40
pubmed: 9150132
Chem Biol. 2013 Apr 18;20(4):570-82
pubmed: 23601646
Cell Stem Cell. 2016 May 5;18(5):587-90
pubmed: 26952870
N Engl J Med. 2016 Dec 15;375(24):2321-2334
pubmed: 26943629
PLoS One. 2017 Mar 24;12(3):e0174483
pubmed: 28339489
Nat Cell Biol. 2007 Sep;9(9):1089-97
pubmed: 17721513
J Biol Chem. 2012 Jan 20;287(4):2280-7
pubmed: 22090026
Future Lipidol. 2007 Aug;2(4):403-422
pubmed: 18176634
Annu Rev Biochem. 2012;81:687-714
pubmed: 22524315
Cell Biosci. 2022 Jul 12;12(1):106
pubmed: 35831869
Biochim Biophys Acta. 2012 Apr;1821(4):607-17
pubmed: 22289388
Nat Commun. 2019 Jan 10;10(1):120
pubmed: 30631056
Cell Stem Cell. 2015 Oct 1;17(4):397-411
pubmed: 26321199
Cell Stem Cell. 2016 Nov 3;19(5):672
pubmed: 27814481
Trends Biochem Sci. 2018 May;43(5):358-368
pubmed: 29500098
Arq Neuropsiquiatr. 2016 Mar;74(3):253-5
pubmed: 27050856
J Lipid Res. 2004 Aug;45(8):1375-97
pubmed: 15254070
Cell Stress. 2021 Aug 25;5(9):143-145
pubmed: 34527863
J Histochem Cytochem. 2011 May;59(5):540-56
pubmed: 21430261
Nature. 2016 May 11;534(7606):267-71
pubmed: 27279226
Nat Commun. 2021 Jul 14;12(1):4303
pubmed: 34262037
Mol Neurobiol. 2019 Apr;56(4):2551-2557
pubmed: 30043260
Sci Rep. 2020 Mar 4;10(1):4040
pubmed: 32132633
PLoS Pathog. 2012 Jan;8(1):e1002468
pubmed: 22241994
Cell Stem Cell. 2016 Nov 3;19(5):663-671
pubmed: 27524440
Intervirology. 2016;59(3):152-158
pubmed: 28081529
Cell Host Microbe. 2010 Nov 18;8(5):422-32
pubmed: 21075353
Cell Rep. 2020 Sep 15;32(11):108132
pubmed: 32937123
Expert Rev Proteomics. 2021 Sep;18(9):809-825
pubmed: 34668810
Trends Endocrinol Metab. 2022 Mar;33(3):218-229
pubmed: 35065875
Cell Host Microbe. 2018 Jun 13;23(6):819-831.e5
pubmed: 29902443
J Biol Chem. 2002 Feb 22;277(8):6344-52
pubmed: 11744721
Nat Rev Microbiol. 2018 Oct;16(10):594-600
pubmed: 29921914
Prostaglandins Leukot Essent Fatty Acids. 2011 Nov;85(5):205-13
pubmed: 21565480
Viruses. 2018 Aug 24;10(9):
pubmed: 30149598
Cell. 2015 Jan 15;160(1-2):177-90
pubmed: 25594180
J Lipid Res. 2009 Apr;50 Suppl:S9-14
pubmed: 19098281
J Virol. 2017 Apr 13;91(9):
pubmed: 28228593
Cell Microbiol. 2017 Jan;19(1):
pubmed: 27794207
Cell. 2002 Aug 23;110(4):489-500
pubmed: 12202038
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Oct;1862(10 Pt B):1260-1272
pubmed: 28735096

Auteurs

Suelen Silva Gomes Dias (SSG)

Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Imunofarmacologia, Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz-Fiocruz, Centro de Pesquisa, Inovação e Vigilância em COVID-19 e Emergências Sanitárias, Rio de Janeiro, RJ, Brasil.

Tamires Cunha-Fernandes (T)

Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Imunofarmacologia, Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz-Fiocruz, Centro de Pesquisa, Inovação e Vigilância em COVID-19 e Emergências Sanitárias, Rio de Janeiro, RJ, Brasil.

Vinicius Cardoso Soares (VC)

Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Imunofarmacologia, Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz-Fiocruz, Centro de Pesquisa, Inovação e Vigilância em COVID-19 e Emergências Sanitárias, Rio de Janeiro, RJ, Brasil.
Universidade Federal do Rio de Janeiro, Programa de Imunologia e Inflamação, Rio de Janeiro, RJ, Brasil.

Cecília Jg de Almeida (CJ)

Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Imunofarmacologia, Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz-Fiocruz, Centro de Pesquisa, Inovação e Vigilância em COVID-19 e Emergências Sanitárias, Rio de Janeiro, RJ, Brasil.

Patricia T Bozza (PT)

Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Imunofarmacologia, Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz-Fiocruz, Centro de Pesquisa, Inovação e Vigilância em COVID-19 e Emergências Sanitárias, Rio de Janeiro, RJ, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH